{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:57:55Z","timestamp":1793447875658,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05352-2","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:55:31Z","timestamp":1785491731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Paracetamol as analgesic and risk of bronchopulmonary dysplasia in extremely preterm infants: a secondary analysis of the BeNeDuctus trial"],"prefix":"10.1038","author":[{"given":"Lindy W.","family":"Hoornenborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura W.","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem P.","family":"de Boode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Villamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hundscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the BeNeDuctus trial study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"5352_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ejp.621","volume":"19","author":"K Brune","year":"2015","unstructured":"Brune, K., Renner, B. & Tiegs, G. Acetaminophen\/Paracetamol: A History of Errors, Failures and False Decisions. Eur. J. Pain. 19, 953\u2013965 (2015).","journal-title":"Eur. J. Pain."},{"key":"5352_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpeds.2021.08.075","volume":"240","author":"A Stark","year":"2022","unstructured":"Stark, A. et al. Medication Use in the Neonatal Intensive Care Unit and Changes from 2010 to 2018.  J. pediatrics 240, 66\u201371. e64 (2022).","journal-title":"J. pediatrics"},{"key":"5352_CR3","unstructured":"Allegaert, K. & van den Anker, J. N. in Seminars in Fetal and Neonatal Medicine. 308-313 (Elsevier)."},{"key":"5352_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jpeds.2015.08.003","volume":"168","author":"A H\u00e4rm\u00e4","year":"2016","unstructured":"H\u00e4rm\u00e4, A., Aikio, O., Hallman, M. & Saarela, T. Intravenous Paracetamol Decreases Requirements of Morphine in Very Preterm Infants.  J. Pediatrics 168, 36\u201340 (2016).","journal-title":"J. Pediatrics"},{"key":"5352_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00228-021-03267-x","volume":"78","author":"A Al-Turkait","year":"2022","unstructured":"Al-Turkait, A., Szatkowski, L., Choonara, I. & Ojha, S. Drug Utilisation in Neonatal Units in England and Wales: A National Cohort Study. Eur. J. Clin. Pharmacol. 78, 669\u2013677 (2022).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"5352_CR6","doi-asserted-by":"publisher","first-page":"e0222667","DOI":"10.1371\/journal.pone.0222667","volume":"14","author":"B Gouyon","year":"2019","unstructured":"Gouyon, B. et al. Characteristics of Prescription in 29 Level 3 Neonatal Wards over a 2-Year Period (2017-2018). An Inventory for Future Research. PLoS One 14, e0222667 (2019).","journal-title":"PLoS One"},{"key":"5352_CR7","doi-asserted-by":"crossref","unstructured":"Weems, M. F. et al. Management of the Patent Ductus Arteriosus among Infants Born at 23 to 32 Weeks\u2019 Gestation between 2011 to 2022: A Report from in the Children\u2019s Hospitals Neonatal Consortium. J Perinatol (2025).","DOI":"10.1038\/s41372-025-02257-6"},{"key":"5352_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/s41372-023-01697-2","volume":"43","author":"CJ Wright","year":"2023","unstructured":"Wright, C. J., McCulley, D. J., Mitra, S. & Jensen, E. A. Acetaminophen for the Patent Ductus Arteriosus: Has Safety Been Adequately Demonstrated? J. Perinatol. 43, 1230\u20131237 (2023).","journal-title":"J. Perinatol."},{"key":"5352_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jpeds.2021.02.026","volume":"235","author":"CJ Wright","year":"2021","unstructured":"Wright, C. J. Acetaminophen and the Developing Lung: Could There Be Lifelong Consequences?  J. pediatrics 235, 264 (2021).","journal-title":"J. pediatrics"},{"key":"5352_CR10","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00080.2022","volume":"323","author":"DJ McCulley","year":"2022","unstructured":"McCulley, D. J. et al. Racing against Time: Leveraging Preclinical Models to Understand Pulmonary Susceptibility to Perinatal Acetaminophen Exposures. Am. J. Physiol.-Lung Cell. Mol. Physiol. 323, L1\u2013L13 (2022).","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"5352_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","volume":"19","author":"H Jaeschke","year":"2024","unstructured":"Jaeschke, H. & Ramachandran, A. Acetaminophen Hepatotoxicity: Paradigm for Understanding Mechanisms of Drug-Induced Liver Injury. Annu. Rev. Pathol.: Mechanisms Dis. 19, 453\u2013478 (2024).","journal-title":"Annu. Rev. Pathol.: Mechanisms Dis."},{"key":"5352_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/17425255.2023.2259787","volume":"19","author":"AL Chiew","year":"2023","unstructured":"Chiew, A. L. & Isbister, G. K. Advances in the Understanding of Acetaminophen Toxicity Mechanisms: A Clinical Toxicology Perspective. Expert Opin. drug Metab. Toxicol. 19, 601\u2013616 (2023).","journal-title":"Expert Opin. drug Metab. Toxicol."},{"key":"5352_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00228-020-03077-7","volume":"77","author":"C Locci","year":"2021","unstructured":"Locci, C., Cuzzolin, L., Capobianco, G. & Antonucci, R. Paracetamol Overdose in the Newborn and Infant: A Life-Threatening Event. Eur. J. Clin. Pharm. 77, 809\u2013815 (2021).","journal-title":"Eur. J. Clin. Pharm."},{"key":"5352_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1165\/rcmb.2024-0452OC","volume":"73","author":"MR Grayck","year":"2025","unstructured":"Grayck, M. R. et al. A Single Early-Life Acetaminophen Exposure Causes Persistent Abnormalities in the Murine Lung. Am. J. Respiratory Cell Mol. Biol. 73, 232\u2013250 (2025).","journal-title":"Am. J. Respiratory Cell Mol. Biol."},{"key":"5352_CR15","doi-asserted-by":"publisher","first-page":"L941","DOI":"10.1152\/ajplung.00234.2021","volume":"321","author":"E Dobrinskikh","year":"2021","unstructured":"Dobrinskikh, E. et al. Pulmonary Implications of Acetaminophen Exposures Independent of Hepatic Toxicity. Am. J. Physiol.-Lung Cell. Mol. Physiol. 321, L941\u2013L953 (2021).","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"5352_CR16","doi-asserted-by":"publisher","first-page":"L969","DOI":"10.1152\/ajplung.00072.2021","volume":"320","author":"E Dobrinskikh","year":"2021","unstructured":"Dobrinskikh, E. et al. The Developing Murine Lung Is Susceptible to Acetaminophen Toxicity. Am. J. Physiol.-Lung Cell. Mol. Physiol. 320, L969\u2013L978 (2021).","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"5352_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJMoa2207418","volume":"388","author":"T Hundscheid","year":"2023","unstructured":"Hundscheid, T. et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N. Engl. J. Med. 388, 980\u2013990 (2023).","journal-title":"N. Engl. J. Med"},{"key":"5352_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12887-018-1215-7","volume":"18","author":"T Hundscheid","year":"2018","unstructured":"Hundscheid, T. et al. Early Treatment Versus Expectative Management of Patent Ductus Arteriosus in Preterm Infants: A Multicentre, Randomised, Non-Inferiority Trial in Europe (Beneductus Trial). BMC Pediatr. 18, 262 (2018).","journal-title":"BMC Pediatr."},{"key":"5352_CR19","first-page":"CD013278","volume":"6","author":"S Mitra","year":"2025","unstructured":"Mitra, S., Scrivens, A., Fiander, M., Disher, T. & Weisz, D. E. Early Treatment Versus Expectant Management of Hemodynamically Significant Patent Ductus Arteriosus for Preterm Infants.  Cochrane database Syst. Rev. 6, CD013278 (2025).","journal-title":"Cochrane database Syst. Rev."},{"key":"5352_CR20","doi-asserted-by":"crossref","unstructured":"Villamor, E., Gal\u00e1n-Henr\u00edquez, G., Barto\u0161, F. & Gonzalez-Luis, G. E. Beneficial Vs Harmful Effects of Pharmacological Treatment of Patent Ductus Arteriosus: A Bayesian Meta-Analysis. Pediatric Research, 1-9 (2025).","DOI":"10.1101\/2024.09.23.24314216"},{"key":"5352_CR21","doi-asserted-by":"crossref","unstructured":"Buvaneswarran, S., Wong, Y. L., Liang, S., Quek, S. C. & Lee, J. Active Treatment Vs Expectant Management of Patent Ductus Arteriosus in Preterm Infants: A Meta-Analysis. JAMA pediatrics (2025).","DOI":"10.1001\/jamapediatrics.2025.1025"},{"key":"5352_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa2305582","volume":"390","author":"S Gupta","year":"2024","unstructured":"Gupta, S. et al. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen. N. Engl. J. Med. 390, 314\u2013325 (2024).","journal-title":"N. Engl. J. Med."},{"key":"5352_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0031-3955(05)70413-2","volume":"43","author":"J Neu","year":"1996","unstructured":"Neu, J. Necrotizing Enterocolitis: The Search for a Unifying Pathogenic Theory Leading to Prevention. Pediatr. Clin. North Am. 43, 409\u2013432 (1996).","journal-title":"Pediatr. Clin. North Am."},{"key":"5352_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723\u20131729 (2001).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"5352_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1542\/peds.2004-0204","volume":"114","author":"MC Walsh","year":"2004","unstructured":"Walsh, M. C. et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114, 1305\u20131311 (2004).","journal-title":"Pediatrics"},{"key":"5352_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen, E. A. et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An Evidence-Based Approach. Am. J. Respir. Crit. Care Med. 200, 751\u2013759 (2019).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"5352_CR27","first-page":"893","volume":"73","author":"S Kn\u00fcppel","year":"2011","unstructured":"Kn\u00fcppel, S. Basics of Using the Dag Programs. Gesundheitswesen (Bundesverb. der Arzte des. Offentlichen Gesundheitsdienstes (Ger.)) 73, 893\u2013896 (2011).","journal-title":"Gesundheitswesen (Bundesverb. der Arzte des. Offentlichen Gesundheitsdienstes (Ger.))"},{"key":"5352_CR28","first-page":"1887","volume":"45","author":"J Textor","year":"2017","unstructured":"Textor, J., van der Zander, B., Gilthorpe, M. S., Li\u015bkiewicz, M. & Ellison, G. T. Robust causal inference using directed acyclic graphs: the R Package \u2018Dagitty\u2019. Int. J. Epidemiol. 45, 1887\u20131894 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"5352_CR29","doi-asserted-by":"crossref","unstructured":"Jensen, E. A. et al. Acetaminophen for Patent Ductus Arteriosus and Risk of Mortality and Pulmonary Morbidity. Pediatrics 154, (2024).","DOI":"10.1542\/peds.2023-065056"},{"key":"5352_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113877","volume":"266","author":"DC Kaluarachchi","year":"2024","unstructured":"Kaluarachchi, D. C. et al. Secular trends in patent ductus arteriosus management in infants born preterm in the national institute of child health and human development neonatal research network. J. Pediatr. 266, 113877 (2024).","journal-title":"J. Pediatr."},{"key":"5352_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41372-019-0347-4","volume":"39","author":"M Liebowitz","year":"2019","unstructured":"Liebowitz, M. et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the Pda-Tolerate Trial (Nct01958320). J. Perinatol. 39, 599\u2013607 (2019).","journal-title":"J. Perinatol."},{"key":"5352_CR32","unstructured":"Laughon, M. M. et al. Expectant management vs medication for patent ductus arteriosus in preterm infants: the pda randomized clinical trial. JAMA (2025)."},{"key":"5352_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","volume":"5","author":"B Th\u00e9baud","year":"2019","unstructured":"Th\u00e9baud, B. et al. Bronchopulmonary dysplasia. Nat. Rev. Dis. Prim. 5, 78 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"5352_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/jpm12050687","volume":"12","author":"M Pierro","year":"2022","unstructured":"Pierro, M., Van Mechelen, K., van Westering-Kroon, E., Villamor-Mart\u00ednez, E. & Villamor, E. Endotypes of prematurity and phenotypes of bronchopulmonary dysplasia: toward personalized neonatology. J. Personalized Med. 12, 687 (2022).","journal-title":"J. Personalized Med."},{"key":"5352_CR35","doi-asserted-by":"publisher","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","volume":"283","author":"TD Le Cras","year":"2002","unstructured":"Le Cras, T. D., Markham, N. E., Tuder, R. M., Voelkel, N. F. & Abman, S. H. Treatment of newborn rats with a Vegf receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L555\u2013L562 (2002).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"5352_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02342-4","volume":"24","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Vascular and pulmonary effects of ibuprofen on neonatal lung development. Respiratory Res. 24, 39 (2023).","journal-title":"Respiratory Res."},{"key":"5352_CR37","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00431-021-04355-x","volume":"181","author":"A Pels","year":"2022","unstructured":"Pels, A. et al. Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the dutch strider study. Eur. J. Pediatr. 181, 1709\u20131718 (2022).","journal-title":"Eur. J. Pediatr."},{"key":"5352_CR38","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1161\/CIRCULATIONAHA.108.845909","volume":"123","author":"C Luong","year":"2011","unstructured":"Luong, C. et al. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia. Circulation 123, 2120\u20132131 (2011).","journal-title":"Circulation"},{"key":"5352_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/uog.20415","volume":"54","author":"AJ Kashyap","year":"2019","unstructured":"Kashyap, A. J. et al. Antenatal sildenafil treatment improves neonatal pulmonary hemodynamics and gas exchange in lambs with diaphragmatic hernia. Ultrasound Obstet. Gynecol. 54, 506\u2013516 (2019).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"5352_CR40","doi-asserted-by":"crossref","unstructured":"Jasani, B., Mitra, S. & Shah, P. S. Paracetamol (Acetaminophen) for Patent Ductus Arteriosus in Preterm or Low Birth Weight Infants. Cochrane Database of Systematic Reviews (2022).","DOI":"10.1002\/14651858.CD010061.pub5"},{"key":"5352_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40272-019-00331-z","volume":"21","author":"B Karabulut","year":"2019","unstructured":"Karabulut, B. & Paytoncu, S. Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants. Paediatr. Drugs 21, 113\u2013121 (2019).","journal-title":"Paediatr. Drugs"},{"key":"5352_CR42","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1038\/s41372-021-01194-4","volume":"41","author":"S Mashally","year":"2021","unstructured":"Mashally, S. et al. Is late treatment with acetaminophen safe and effective in avoiding surgical ligation among extremely preterm neonates with persistent patent ductus arteriosus? J. Perinatol. 41, 2519\u20132525 (2021).","journal-title":"J. Perinatol."},{"key":"5352_CR43","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/j.jtcvs.2018.05.098","volume":"156","author":"S Mashally","year":"2018","unstructured":"Mashally, S. et al. Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus. J. Thorac. Cardiovasc Surg. 156, 1937\u20131944 (2018).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"5352_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07679-y","volume":"15","author":"JAC Orvay","year":"2025","unstructured":"Orvay, J. A. C., Baucells, B. J., Aloy, J. F., Echegoyen, X. M. & Sebastiani, G. Trends in bronchopulmonary dysplasia and 15-year evolution in respiratory and hemodynamic management of very premature infants. Sci. Rep. 15, 24987 (2025).","journal-title":"Sci. Rep."},{"key":"5352_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/archdischild-2020-319069","volume":"106","author":"S Juuj\u00e4rvi","year":"2021","unstructured":"Juuj\u00e4rvi, S., Saarela, T., Pokka, T., Hallman, M. & Aikio, O. Intravenous Paracetamol for Neonates: Long-Term Diseases Not Escalated during 5 Years of Follow-Up. Arch. Dis. Child Fetal Neonatal Ed. 106, 178\u2013183 (2021).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"5352_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/archdischild-2012-303043","volume":"100","author":"M Cheelo","year":"2015","unstructured":"Cheelo, M. et al. Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis. Arch. Dis. Child. 100, 81\u201389 (2015).","journal-title":"Arch. Dis. Child."},{"key":"5352_CR47","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1002\/ppul.25595","volume":"56","author":"M Singh","year":"2021","unstructured":"Singh, M. et al. Paracetamol exposure and asthma: what does the evidence say? An overview of systematic reviews. Pediatr. Pulmonol. 56, 3189\u20133199 (2021).","journal-title":"Pediatr. Pulmonol."},{"key":"5352_CR48","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/bcp.13656","volume":"84","author":"J McCrae","year":"2018","unstructured":"McCrae, J., Morrison, E., MacIntyre, I., Dear, J. & Webb, D. Long-term adverse effects of paracetamol\u2013a review. Br. J. Clin. Pharmacol. 84, 2218\u20132230 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"5352_CR49","doi-asserted-by":"crossref","unstructured":"Katz, T. A. et al. Prognostic accuracy of Bpd definitions for long-term outcomes in preterm infants: a systematic review. Pediatrics 156, (2025).","DOI":"10.1542\/peds.2025-070741"},{"key":"5352_CR50","doi-asserted-by":"crossref","unstructured":"Katz, T. A. et al. Toward a harmonized bronchopulmonary dysplasia definition: an international delphi process. Pediatrics (2026).","DOI":"10.1542\/peds.2025-074308"},{"key":"5352_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/ACI.0b013e3283609831","volume":"13","author":"D Curran-Everett","year":"2013","unstructured":"Curran-Everett, D. & Milgrom, H. Post-Hoc data analysis: benefits and limitations. Curr. Opin. Allergy Clin. Immunol. 13, 223\u2013224 (2013).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"5352_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2381-x","volume":"19","author":"RE Farmer","year":"2018","unstructured":"Farmer, R. E. et al. Application of causal inference methods in the analyses of randomised controlled trials: a systematic review. Trials 19, 23 (2018).","journal-title":"Trials"},{"key":"5352_CR53","doi-asserted-by":"crossref","unstructured":"Smith, M. J. Using directed acyclic graphs to inform statistical analysis plans in pediatric research. J. Pediatr. 265, (2024).","DOI":"10.1016\/j.jpeds.2023.113821"},{"key":"5352_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41390-018-0071-3","volume":"84","author":"TC Williams","year":"2018","unstructured":"Williams, T. C., Bach, C. C., Matthiesen, N. B., Henriksen, T. B. & Gagliardi, L. Directed acyclic graphs: a tool for causal studies in paediatrics. Pediatr. Res. 84, 487\u2013493 (2018).","journal-title":"Pediatr. Res."},{"key":"5352_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jclinepi.2022.05.021","volume":"149","author":"A van Zwieten","year":"2022","unstructured":"van Zwieten, A. et al. Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer. J. Clin. Epidemiol. 149, 127\u2013136 (2022).","journal-title":"J. Clin. Epidemiol."},{"key":"5352_CR56","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim, J. H. Multicollinearity and misleading statistical results. Korean J. Anesthesiol. 72, 558\u2013569 (2019).","journal-title":"Korean J. Anesthesiol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05352-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:47:57Z","timestamp":1790657277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":56,"alternative-id":["5352"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05352-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was approved by the Medical Ethics Committee of Radboud University (CMO Arnhem-Nijmegen; Number 2016-2552\/NL57885.091.16), the Medical Ethics Committee of the Cliniques Universitaires de Bruxelles \u2013 H\u00f4pital Erasme (P2018\/177) and the Central Denmark Region Committees on Health Research Ethics (no. 1-10-72-190-19). Local approval was obtained in all participating centers after approval of the national coordinating center. Informed consent was obtained from the parents of all participants in the trial.","order":2,"name":"Ethics","label":"Consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}